NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

9479	Companies
185510	Keywords
117899	Articles
99364	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 03/27/2025 at 21:15, 8 months 8 days ago

Nanobiotix annonce les premières données issues de la partie escalade de dose completée d’une étude de Phase 1 évaluant JNJ-1900 (NBTXR3) en traitement de 2L+ pour les patients atteints d’un CPNPC localement avancé
Nanobiotix annonce les premières données prometteuses de l'étude de phase 1 évaluant JNJ-1900 (NBTXR3) en traitement de 2L+ pour les patients atteints d'un CPNPC localement avancé

Traitement NANOBIOTIX CPNPC Phase 1 JNJ-1900
BRIEF

published on 03/20/2025 at 21:20, 8 months 15 days ago

Nanobiotix dévoile des résultats de Phase 1 au Congrès Européen sur le Cancer du Poumon

Biotechnologie NANOBIOTIX Cancer Du Poumon Phase 1 JNJ-1900
BRIEF

published on 03/20/2025 at 21:20, 8 months 15 days ago

Nanobiotix Unveils Phase 1 Results at European Lung Cancer Congress

Biotechnology NANOBIOTIX Lung Cancer Phase 1 JNJ-1900
PRESS RELEASE

published on 03/20/2025 at 21:15, 8 months 15 days ago

NANOBIOTIX annonce la présentation de données issues de deux études de phase 1 évaluant JNJ-1900 (NBTXR3) lors du Congrès Européen sur le Cancer du Poumon
Nanobiotix annonce la présentation de données de deux études de Phase 1 évaluant JNJ-1900 (NBTXR3) lors du Congrès Européen sur le Cancer du Poumon 2025

NANOBIOTIX Cancer Du Poumon JNJ-1900 Études De Phase 1 ELCC 2025
PRESS RELEASE

published on 03/20/2025 at 21:15, 8 months 15 days ago

NANOBIOTIX Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference
Nanobiotix announces presentation of data from two Phase 1 studies evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference. Studies highlight safety, efficacy, and collaboration strategies

Collaboration NANOBIOTIX Lung Cancer JNJ-1900 Phase 1 Studies
BRIEF

published on 03/17/2025 at 21:20, 8 months 18 days ago

NANOBIOTIX Prolonge son Horizon Financier jusqu'à mi-2026

Accord De Licence NANOBIOTIX NBTXR3 Visibilité Financière Janssen
BRIEF

published on 03/17/2025 at 21:20, 8 months 18 days ago

NANOBIOTIX Extends its Financial Horizon until mid-2026

License Agreement NANOBIOTIX NBTXR3 Financial Visibility Janssen
PRESS RELEASE

published on 03/17/2025 at 21:15, 8 months 18 days ago

NANOBIOTIX renforce sa visibilité financière en amendant son accord de licence globale pour JNJ-1900 (NBTXR3) qui étend son horizon de trésorerie jusqu’à mi-2026
Nanobiotix renforce sa visibilité financière en amendant son accord de licence avec JNJ-1900 (NBTXR3), étendant son horizon de trésorerie jusqu’à mi-2026. Conférence le 18/03/2025

Trésorerie Accord De Licence NANOBIOTIX Visibilité Financière JNJ-1900
PRESS RELEASE

published on 03/17/2025 at 21:15, 8 months 18 days ago

NANOBIOTIX Strengthens Financial Position Through Amendment of Global Licensing Agreement for JNJ-1900 (NBTXR3) and Extends Cash Visibility to Mid-2026
Nanobiotix strengthens financial position by amending global licensing agreement for JNJ-1900 (NBTXR3), extending cash visibility to mid-2026. Details of the amendment and future potential milestone payments outlined

Financial Position Milestone Payments NANOBIOTIX JNJ-1900 Global Licensing Agreement
BRIEF

published on 03/13/2025 at 22:20, 8 months 22 days ago

Nanobiotix Reports Voting Rights and Share Capital Details

Euronext Paris Voting Rights Financial Transparency NANOBIOTIX Shares Outstanding

Accesswire

Published on 12/05/2025 at 17:15, 54 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 1 hour 9 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 2 hours 9 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 2 hours 24 minutes ago

Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 2 hours 24 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 17:51, 17 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 23 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:00, 1 hour 9 minutes ago

EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 16:25, 1 hour 44 minutes ago

4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 1 hour 59 minutes ago

Reorganization of the Eckert & Ziegler Executive Board

Les Echos

Published on 12/05/2025 at 17:18, 51 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 51 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 2 hours 58 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 2 hours 58 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 4 hours 11 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE